Diagu, a Poznan, Poland-based MedTech startup that is building the next generation of medical testing solutions, raised $2 million in Seed funding.
The round was led by Airspeed Equity and FasterCapital.
Diagu plans to invest millions of dollars toward expanding the range of tests it assesses. Diagu plans to significantly expand its partnerships with diagnostic laboratories around the world toward joint commercialization of its solution, with medical equipment providers, and with teaching hospitals.
Company: Diagu Ltd.
Round: Seed Round
Funding Month: October 2021
Lead Investors: Airspeed Equity and FasterCapital.
Company Website: https://diagu.com/
Software Category: Medical testing solutions
About the Company: Diagu machine learning system evaluates the results of laboratory tests of patients and other collected data, such as medical history, previous diagnoses, or medications taken, to effectively assess diseases. In addition to the diagnosis, the system also suggests further treatment or change of the current one. Diagu unique market approach to combine AI + Big Data with clinical information could help millions of people with similar symptoms to be diagnosed faster and more accurately.